Cutler Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,900
| Closed | -$1K | – | 2229 |
|
|
2023
Q4 | $1K | Buy |
4,900
+3,700
| +308% | +$1.01M | ﹤0.01% | 3246 |
|
|
2023
Q3 | $6K | Buy |
1,200
+600
| +100% | +$150K | ﹤0.01% | 2733 |
|
|
2023
Q2 | $18K | Sell |
600
-100
| -14% | -$23.2K | ﹤0.01% | 1893 |
|
|
2023
Q1 | $14K | Sell |
700
-29,500
| -98% | -$7.24M | ﹤0.01% | 2090 |
|
|
2022
Q4 | $54K | Sell |
30,200
-4,800
| -14% | -$1.29M | ﹤0.01% | 1516 |
|
|
2022
Q3 | $289K | Sell |
35,000
-10,400
| -23% | -$2.52M | 0.02% | 789 |
|
|
2022
Q2 | $299K | Buy |
45,400
+7,500
| +20% | +$1.84M | 0.02% | 772 |
|
|
2022
Q1 | $107K | Buy |
37,900
+31,600
| +502% | +$7.26M | 0.01% | 1640 |
|
|
2021
Q4 | $18K | Buy |
+6,300
| New | +$1.33M | ﹤0.01% | 3198 |
|
|
2021
Q1 | – | Sell |
-11,000
| Closed | -$27K | – | 5561 |
|
|
2020
Q4 | $27K | Buy |
11,000
+1,000
| +10% | +$231K | ﹤0.01% | 2443 |
|
|
2020
Q3 | $3K | Buy |
10,000
+9,000
| +900% | +$2.23M | ﹤0.01% | 3770 |
|
|
2020
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 3937 |
|
|
2020
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 2961 |
|
|
2019
Q4 | $1K | Sell |
1,000
-2,500
| -71% | -$551K | ﹤0.01% | 3589 |
|
|
2019
Q3 | $10K | Sell |
3,500
-14,600
| -81% | -$2.8M | ﹤0.01% | 2611 |
|
|
2019
Q2 | $36K | Buy |
18,100
+13,100
| +262% | +$2.35M | ﹤0.01% | 1784 |
|
|
2019
Q1 | $7K | Sell |
5,000
-1,400
| -22% | -$267K | ﹤0.01% | 2693 |
|
|
2018
Q4 | $6K | Buy |
6,400
+2,000
| +45% | +$390K | ﹤0.01% | 2802 |
|
|
2018
Q3 | $7K | Buy |
+4,400
| New | +$867K | ﹤0.01% | 2833 |
|
|
2018
Q2 | – | Sell |
-4,700
| Closed | -$25K | – | 4139 |
|
|
2018
Q1 | $25K | Sell |
4,700
-14,600
| -76% | -$2.68M | ﹤0.01% | 2119 |
|
|
2017
Q4 | $5K | Sell |
19,300
-6,600
| -25% | -$1.17M | ﹤0.01% | 3577 |
|
|
2017
Q3 | $28K | Sell |
25,900
-20,100
| -44% | -$3.56M | ﹤0.01% | 2792 |
|
|
2017
Q2 | $52K | Sell |
46,000
-18,800
| -29% | -$3.06M | ﹤0.01% | 2450 |
|
|
2017
Q1 | $489K | Buy |
64,800
+47,900
| +283% | +$7.96M | 0.02% | 652 |
|
|
2016
Q4 | $177K | Sell |
16,900
-3,500
| -17% | -$527K | 0.01% | 1389 |
|
|
2016
Q3 | $72K | Sell |
20,400
-10,600
| -34% | -$1.79M | ﹤0.01% | 2107 |
|
|
2016
Q2 | $215K | Buy |
31,000
+16,900
| +120% | +$2.63M | 0.01% | 1072 |
|
|
2016
Q1 | $120K | Buy |
14,100
+8,600
| +156% | +$1.28M | 0.01% | 1441 |
|
|
2015
Q4 | $3K | Buy |
+5,500
| New | +$865K | ﹤0.01% | 5214 |
|
Other funds holding AMGN
Cutler Group's AMGN Position: Q1 2024 in Review
Cutler Group reduced its Amgen (AMGN) stake by 68% in Q1 2024, selling an estimated $19.9K and leaving 32 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.
Cutler Group first reported a position in AMGN in Q4 2015 and has held it in 27 quarters since. The position peaked at $8.33M in Q1 2017. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.
- Cutler Group held 32 shares of Amgen worth $9K as of Q1 2024.
- Cutler Group sold 68 Amgen shares in Q1 2024, an estimated $19.9K.
- Amgen made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1297 holding.
- Cutler Group first reported a position in Amgen in Q4 2015 and has held it in 27 quarters since.
- Cutler Group's Amgen position peaked at $8.33M in Q1 2017.
- 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.